Answers are grounded in this paper and cite their sources.
Direct RNA sequencing identifies 57,000 m6A sites across 15,000 isoforms in three brain regions, highlighting their specific functional roles.
The RNA modification N6-methyladenosine (m6A) is highly abundant in human brain and implicated in neurological disorders. Profiling m6A within RNA isoforms is a critical step toward understanding the complex mechanisms that underpin brain function and disease; however, we lack an isoform-level atlas of m6A sites in the brain. We applied Oxford Nanopore direct RNA sequencing (DRS) to three postmortem human brain regions-prefrontal cortex, caudate nucleus, and cerebellum-to simultaneously investigate the transcriptome and epitranscriptome at the isoform level. We identified 57,000 m6A sites within 15,000 isoforms, revealing both isoform- and brain region-specific patterning of m6A modifications. The prefrontal cortex exhibited a distinctive profile of specifically modified isoforms enriched in excitatory neurons and had the highest proportion of unannotated m6A sites. A population of isoforms were hypermodified and associated with excitatory neurons in all brain regions. Our results demonstrate the utility of isoform-level profiling of RNA modifications and provide insights into brain region specificity with implications for development and disease.
No takes yet. Share an insight, caveat, or question.
Gleeson et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: